Moderna completes enrollment for phase 2 coronavirus vaccine trial
Protocol for the phase 3 study has already been finalized, following feedback Moderna received from the US Food and Drug Administration.
A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020(photo credit: REUTERS/BRIAN SNYDER)ByJERUSALEM POST STAFF
